Her primary areas of study are Neuroscience, Dystonia, Cerebellum, Basal ganglia and Putamen. Maren Carbon specializes in Neuroscience, namely Brain mapping. Her research investigates the link between Dystonia and topics such as Supplementary motor area that cross with problems in Prefrontal cortex and Control subjects.
Her research integrates issues of Deep brain stimulation, Motor control, Functional imaging, Neuroimaging and Dystonic disorder in her study of Cerebellum. Her Deep brain stimulation research incorporates themes from Cerebral blood flow, Cardiology, Levodopa, Dyskinesia and Globus pallidus. The Disease study combines topics in areas such as Nerve net and Cognition.
The scientist’s investigation covers issues in Neuroscience, Dystonia, Psychiatry, Parkinson's disease and Internal medicine. She usually deals with Neuroscience and limits it to topics linked to Deep brain stimulation and Parkinsonism. Her work on Dystonic disorder as part of general Dystonia study is frequently connected to Fractional anisotropy, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Her work in Parkinson's disease covers topics such as Cognition which are related to areas like Nerve net and Disease. Her Internal medicine research is multidisciplinary, incorporating perspectives in Parietal lobe, Endocrinology and Global Assessment of Functioning. As a part of the same scientific study, Maren Carbon usually deals with the Basal ganglia, concentrating on Movement disorders and frequently concerns with Neuroplasticity.
Tardive dyskinesia, Meta-analysis, Psychiatry, Internal medicine and Olanzapine are her primary areas of study. Her Meta-analysis study combines topics from a wide range of disciplines, such as Odds ratio, Rate ratio, Incidence and Antipsychotic. Her Antipsychotic study incorporates themes from Young adult, Pediatrics and Confounding.
Her Psychiatry research includes themes of Occupational safety and health and Retrospective cohort study. Her studies in Internal medicine integrate themes in fields like Mood, Mania and Global Assessment of Functioning. Maren Carbon interconnects Aripiprazole, Controlled studies, Adverse effect and Bioinformatics in the investigation of issues within Olanzapine.
Maren Carbon mainly focuses on Meta-analysis, Internal medicine, Antipsychotic, Tardive dyskinesia and Relative risk. Her Internal medicine research integrates issues from Aripiprazole and Olanzapine. Her Aripiprazole research is multidisciplinary, incorporating elements of Rate ratio and Clozapine.
Her Olanzapine study is related to the wider topic of Psychiatry. Maren Carbon has researched Parkinsonism in several fields, including Deutetrabenazine, Valbenazine and Cross-sectional study. The various areas that Maren Carbon examines in her Odds ratio study include Young adult, Adverse effect, Incidence and Confounding.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The role of radiotracer imaging in Parkinson disease
B. Ravina;D. Eidelberg;J. E. Ahlskog;R. L. Albin.
Metabolic brain networks associated with cognitive function in Parkinson's disease.
Chaorui Huang;Paul J. Mattis;Chengke Tang;Chengke Tang;Kenneth Perrine.
Cerebellothalamocortical connectivity regulates penetrance in dystonia.
Miklos Argyelan;Maren Carbon;Martin Niethammer;Aziz M. Uluğ.
The Journal of Neuroscience (2009)
Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents.
Christoph U. Correll;Julie B. Penzner;Umesh H. Parikh;Tahir Mughal.
Child and Adolescent Psychiatric Clinics of North America (2006)
Impaired sequence learning in carriers of the DYT1 dystonia mutation.
Maria-Felice Ghilardi;Maren Carbon;Giulia Silvestri;Vijay Dhawan.
Annals of Neurology (2003)
Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysis
Britta Galling;Alexandra Roldán;René E Nielsen;Jimmi Nielsen.
JAMA Psychiatry (2016)
Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis.
Maren Carbon;Cheng-Hsi Hsieh;John M. Kane;Christoph U. Correll.
The Journal of Clinical Psychiatry (2017)
Clinical predictors of therapeutic response to antipsychotics in schizophrenia.
Maren Carbon;Christoph U Correll.
Dialogues in Clinical Neuroscience (2014)
Abnormal structure-function relationships in hereditary dystonia
Maren Carbon;David Eidelberg;David Eidelberg.
Microstructural white matter changes in carriers of the DYT1 gene mutation.
Maren Carbon;Peter B. Kingsley;Sherwin Su;Gwenn S. Smith.
Annals of Neurology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: